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Abstract
Sepsis is characterized by a generalized inflammatory response and organ failure, associated with mitochondrial
dysfunction. Hydrogen sulfide donor NaHS has anti-inflammatory properties, is able to reduce metabolism and can preserve
mitochondrial morphology and function. Rats were challenged with live Streptococcus pneumonia or saline and infused with
NaHS (36 mmol/kg/h) or vehicle. Lung and kidney injury markers were measured as well as mitochondrial function, viability
and biogenesis. Infusion of NaHS reduced heart rate and body temperature, indicative of a hypo–metabolic state. NaHS
infusion reduced sepsis–related lung and kidney injury, while host defense remained intact, as reflected by unchanged
bacterial outgrowth. The reduction in organ injury was associated with a reversal of a fall in active oxidative phosphorylation
with a concomitant decrease in ATP levels and ATP/ADP ratio. Preservation of mitochondrial respiration was associated with
increased mitochondrial expression of a–tubulin and protein kinase C–e, which acts as regulators of respiration.
Mitochondrial damage was decreased by NaHS, as suggested by a reduction in mitochondrial DNA leakage in the lung. Also,
NaHS treatment was associated with upregulation of peroxisome proliferator-activated receptor–c coactivator 1a, with a
subsequent increase in transcription of mitochondrial respiratory subunits. These findings indicate that NaHS reduces organ
injury in pneumosepsis, possibly via preservation of oxidative phosphorylation and thereby ATP synthesis as well as by
promoting mitochondrial biogenesis. Further studies on the involvement of mitochondria in sepsis are required.
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Introduction
Streptococcus pneumoniae is the leading cause of community
acquired pneumonia in patients that require admission to the
intensive care unit [1]. Infection with S. pneumoniae triggers an
intense inflammatory reaction, which can lead to sepsis and
multiple organ failure, including acute lung injury and acute
kidney injury. Supportive treatment aims to enhance substrate and
oxygen delivery to tissues to produce adenosine triphosphate
(ATP), thereby preserving the bio–energetic status of organs [2].
However, despite adequate supportive treatment, mortality of
sepsis remains high [3].
The mechanisms which underlie sepsis–induced organ injury
are complex. The inflammatory response can directly damage
mitochondrial DNA, lipids and respiratory complexes, thereby
inhibiting oxidative phosphorylation [4] and diminishing ATP
availability [2]. In sepsis, mitochondrial dysfunction is associated
with adverse outcome [5]. Influencing mitochondrial substrate
utilization was shown to improve outcome in sepsis [6–8], which
may be due to preserved mitochondrial structure and function [9],
thereby preserving local ATP levels.
Regulation of cellular metabolism is complex and involves
various nuclear transcription factors [10]. Upon stress stimula-
tion, peroxisome proliferator-activated receptor-c coactivator
(PGC)–1a rapidly induces the upregulation of transcription
factors resulting in transcription of mitochondrial (mt) DNA,
with subsequent formation of several subunits of respiratory
complexes inside the mitochondria, including cytochrome c
oxidase (COX) 1, NADH1 and NADH6 [10]. Expansion of
respiratory complexes increases oxidative phosphorylation and
thereby ATP production. ATP availability is regulated by
VDAC, a voltage-dependent porin, embedded in the outer
membrane of the mitochondria [11]. ATP is transported from
the matrix to the cytosol through VDAC in exchange for ADP
and phosphate. The function of VDAC is partly regulated by
a–tubulin and protein kinase C (PKC)–e, which can induce
closure of VDAC [12], thereby reducing the exchange of ATP
with ADP to the cytosol.
Hydrogen sulfide (H2S) is an inhibitor of mitochondrial
respiration [13] and has been shown to induce a shift in
mitochondrial substrate utilization [14], to improve mitochon-
drial function during ischemic injury [13] and to maintain ATP
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production under hypoxic conditions [15]. Also, H2S has anti–
inflammatory properties [16]. In sufficient doses, H2S can
induce a ‘hibernation–like state’, characterized by hypothermia
and low CO2 production and O2 consumption [17]. Infusion of
H2S donor NaHS has been shown to reduce lung injury in a
rat model of ventilator induced lung injury [18]. Furthermore, a
bolus NaHS improved survival when injected simultaneously at
the time of induction of sepsis [19] in mice. However, NaHS
has a short half life [16]. The effect of extended infusion of high
doses of NaHS during sepsis is unknown. Also, the mechanism
of the effects of NaHS on mitochondrial function is not known.
In the present study, we hypothesized that NaHS protects
against organ damage in a rat model of pneumococcal
pneumosepsis by improving bio–energetic status. Furthermore,
we studied the pathways by which H2S may regulates mitochon-
drial function.
Methods
The study was approved by the animal care and use committee
of the Academic Medical Centre, Amsterdam, the Netherlands.
Animal procedures were carried out in compliance with Institu-
tional Standards for Human Care and Use of Animal Laboratory
Animals.
Induction of Pneumonia
Rats (Sprague Dawley 6350 g, Harlan, The Hague, The
Netherlands) were intratracheally inoculated with ,66106 CFU
of aerosolized S. pneumoniae serotype 3 (ATCC 6303; Rockville,
MD, USA) using a trans–oral miniature nebulizer under light
anesthesia (97% oxygen with 3% isoflurane). Controls received
saline. Supplemental fluids were given after inoculation and every
24 hours by intraperitoneal injection of 10 ml/kg of lactated
Ringer’s solution.
H2S Donor
Preparations of a H2S donor were made fresh on the day of the
experiments as described before [18]. NaHS was infused at
36 mmol/kg/h intravenously.
Experimental Protocol and Groups
Two days after inoculation with S. pneumoniae rats were
anesthetized with intraperitoneal injection of a mix (0.15 ml/
100 g body weight) containing 90 mg/kg ketamine, 0.5 mg/kg
medetomidine and 0.05 mg/kg atropine. Anesthesia was main-
tained by infusion of 50 mg/kg ketamine at 0.5 ml/100 g/hr.
Bicarbonate (8.4%) was administered at 1 ml/100 g/hr to
maintain normal acid-base balance [20]. A tracheotomy was
performed, after which a metal canule was connected to a
ventilator (Servo 900C, Siemens, Sweden). Ventilator settings were
determined in pilot experiments aiming at normo-pH (7.35–7.45)
and tidal volumes of ,7.5 ml/kg [18]. Detailed ventilatory
settings are described in supplementary data. Hemodynamic
monitoring was done by a carotid artery catheter connected to a
monitor. Urine was collected. After baseline measurements, the
animals were randomized to infusion with saline or NaHS, with
equal volume load. In the saline control groups, body temperature
was maintained at 37uC.
Exsanguination and Assays
The rats were sacrificed after 4 hours of mechanical ventilation.
Lungs were removed en block. BALF was obtained by flushing the
left lung (362.5 ml saline) after ligation of the right lung. Cell
counts were determined using a hematocytometer (Z2 Coulter
Particle Counter, Beckman Coulter; Florida, USA) and cell
differentiation were done on Giemsa-stained cytospins in bron-
choalveolar lavage fluid (BALF). Interleukin (IL)–1b, IL–6, TNF–
a and CINC3 (R&D Systems; Abingdon, United Kingdom) were
measured in BALF and plasma. Alkaline phosphatase (AF) levels
were measured by a commercially available kit (Sigma Aldrich, St.
Lous, MO) in BALF supernatant using a Hitachi analyzer (Roche
BV, Mannheim, Germany). Plasma levels of aspartate amino–
transaminase and alanine–transaminase were measured using
standard enzymatic methods at 37uC and creatinine by enzymatic
PAP (Roche Diagnostics, the Netherlands). To measure protein
carbonyls, lung and liver sample (6200 mg) were prepared
according to the manufacturers’ instruction (Cayman chemical
company, Ann Arbor, Michigan, USA). Glomerular filtration rate
was calculated by ([creatinine] urine6urine volume in 24 hours)/
[creatinine] plasma.
Bacterial Outgrowth, Wet Weight and Histopathology
Approximately 0.5 g of lung, liver and spleen tissues were
removed, diluted 1:4 in sterile saline and homogenized. The
number of colonizing forming units (CFU) was determined by
performing 10-fold dilutions in blood, BALF and organ homog-
enates on blood agar plates, after 24 hours of incubation at 37uC
with 5% CO2. The right lung top was Hematoxylin–Eosin (H&E)
stained and analyzed by a pathologist who was blinded for group
identity. Interstitial inflammation, endothelialitis, bronchitis, ede-
ma and pleuritis were scored on a scale of 0–4:0 for normal lungs,
1 for ,25% lung involvement, 2 for 25 2 50% involvement, 3 for
50275% involvement and 4 for .75% lung involvement. Total
histology score is the sum score of all parameters. The remaining
right lobes were weighted to determine wet weight, as was the right
kidney.
Mitochondrial Viability Measurements
Part of the liver was removed by modified freeze clamping and
placed in liquid nitrogen for ATP and adenosine diphosphate
(ADP) measurements and part was placed in isolation buffer. This
was done before exsanguination to ensure mitochondrial viability
and minimize ATP degradation. Mitochondria were isolated by
differential centrifugation steps and respiration was measured
polarographically at 37uC using a respiratory system (System S
200A, Strathkelvin Instruments, Glasgow, Scotland). ATP and
ADP levels were analysed by HPLC method [21]. The expression
of VDAC and its regulators, including a–tubulin and phosphor
PKC-e were measured at protein level in the mitochondrial
fraction by western blot. Expression of VDAC and a-tubulin was
normalized to expression of prohibitin. Expression of phosphor-
ylated PKCe is shown as a ratio to total PKCe. Expression of
PGC1-a, and mtDNA (COX1, NADH1 and NADH6) were
measured in liver and lung tissue as well as in plasma and BALF.
See methods S1 for more detailed description.
Statistical Analysis
Data are expressed as mean with SD in the tables and in the
figures as mean with SEM. Bacterial outgrowth data was analyzed
by Mann-Whitney U test or unpaired t-test according to data
distribution. Intergroup differences were analyzed by analysis of
variance (ANOVA) and Bonferroni’s post–hoc test, or by a
Kruskal Wallis test with Mann2Whitney U test dependent on data
distribution. A p value of ,0.05 was considered significant.
Statistical analyses were done using Prism (Graphpad Prism 5, CA,
USA).
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Results
S. pneumoniae Resulted in Severe Pneumosepsis,
Characterized by Lung Injury, Systemic Inflammation,
Organ Injury and Low Bio-energetic Status
After inoculation with S. pneumoniae but before NaHS infusion,
the mortality rate was 11%. These animals were not included. The
remaining animals were randomized to NaHS or vehicle infusion.
Mean arterial pressure remained above 70 mmHg (table 1).
Inoculation resulted in severe macroscopic pneumonia. Hemato-
genic spread of bacteria was demonstrated by positive cultures of
liver or spleen in all animals (figure S1).
Pneumonia increased bronchoalveolar lavage fluid (BALF)
protein content and lung wet weight compared to non-infected
controls (p,0.05, figure 1C+D), accompanied by an enhanced
pulmonary cell- and neutrophil influx (p,0.05, figure 1B),
increased BALF levels of IL-1b, IL-6, TNF-a and CINC3
(p,0.05 for all, figure 1E–H) in addition to lung histopathological
abnormalities (p,0.05, figure 2). Pneumonia resulted in increased
levels of AF (48.5610.4 vs. 29.163.7 U/L, p,0.05) in the BALF
compared to non-infected controls, indicating cell damage.
Pulmonary injury was accompanied by a decrease in arterial
pO2 (p,0.05, table S1) and required higher respiratory frequen-
cies and peak airway pressure to maintain normo-pH (p,0.05,
table S1) compared to non-infected controls. Systemically,
pneumonia caused modest inflammation, with increased plasma
levels of IL-6, but not of TNF–a, IL-1b and CINC3 when
compared to non-infected controls (p,0.05, figure S2). Pneumo-
nia resulted in an increase in kidney wet weight and urine protein
content (both p,0.05, table 1), indicating kidney vascular damage
and permeability edema. Plasma levels of ALT, but not AST, were
increased during pneumonia (p,0.05, table 1). No histopatholog-
ical abnormalities were observed on liver and kidney H&E stained
slides.
Pneumosepsis-induced inflammatory responses and organ
injury were accompanied by oxidative damage, reflected in higher
protein carbonyl levels in both organs (p,0.05, figure 3A+B).
Mitochondrial oxygen consumption when challenged with sub-
strate for complex I was markedly decreased during pneumosepsis
compared to non-infected controls (p,0.05, figure 3C+D), with a
concomitant decrease in ATP and ATP/ADP ratios (p,0.05,
figure 3G+H). Respiration when challenged with substrate for
complex II was unchanged in sepsis (figure 3E+F). VDAC
expression on the other hand was increased during pneumosepsis,
reflecting a low bio-energetic status and enhanced ATP demand
(p,0.05, figure 4B). Also a-tubulin was increased compared to
non-infected controls (p,0.05, figure 4C+D). Low bio–energetic
status was associated with decreased PGC1–a expression, a
metabolism regulator [10] with concomitant low expression of
mitochondrial respiratory subunit NADH6 in the lung (p,0.05,
figure 5A+G) as compared to non-infected controls. Expressions of
other subunits were not affected.
NaHS did not Alter Bacterial Outgrowth of S. pneumoniae
NaHS did not influence bacterial outgrowth in BALF and lung
homogenates compared to saline controls, nor did it influence
bacterial outgrowth in distant organs (figure S1). NaHS tended to
decrease the number of positive blood cultures (38% vs. 13% in
saline controls, p = 0.13).
NaHS Reduced Heart Rate, Body Temperature and
Improved Gas Exchange
In line with our previous experiments [18], infusion of NaHS
reduced heart rate and body temperature compared to saline
controls, both in pneumonia and in healthy rats, without an effect
on mean arterial pressure (all p,0.05, table 1). NaHS allowed for
a reduction in respiratory rates compared to saline controls while
maintaining normo-pH, with 20% reduction in infected and 26%
in non-infected animals (p,0.05, table S1). NaHS prevented a fall
in arterial pO2 in pneumonia and increased oxygenation in the
healthy animals (p,0.05, table S1), but did not influence peak
airway pressure.
NaHS Reduced Local and Systemic Inflammation and
Ameliorated Kidney Function in Pneumosepsis
NaHS reduced BALF protein concentration compared to saline
controls (p,0.05, figure 1C), but did not reduce pulmonary
edema. Also, NaHS reduced pulmonary cell counts and neutro-
phils influx as well as BALF levels of IL-6 and TNF-a (all p,0.05,
figure 1E+F). NaHS non-significantly decreased BALF levels of
IL-1b and CINC3 compared to saline controls (p = 0.08 and 0.18
respectively, figure 1G+H). Inhibition of inflammation by NaHS
was also reflected in the lung histopathology score, in particular
interstitial inflammation (p,0.05, figure 2). NaHS did not affect
AF concentration (48.5610.4 vs. 29.163.7 U/L) compared to
saline controls. NaHS decreased systemic levels of IL-6 (p,0.05,
figure S2A), but levels of TNF-a, IL-1b and CINC3 were not
altered. NaHS infusion reduced kidney wet weight and protein loss
in the urine (both p,0.05, table 1), together with an improved
glomerular filtration rate and reduced plasma creatinine levels
compared to saline controls (p,0.05, table 1), while cumulative
fluid infusion nor diuresis differed. Liver enzymes were reduced by
NaHS, which did not reach statistical significance due to a wide
range (p = ns, table 1).
Table 1. Physiological parameters at baseline and after 4
hours and organ function markers of rats with pneumonia or
healthy controls after 4 hours of NaHS infusion or saline.
Pneumonia Healthy
Time
(Hour) Saline NaHS Saline NaHS
MAP, (mmHg) T = 0 120623 121623 127620 140616
T = 4 91624 95619 106620 101623
Heart rate,
(beats/min)
T = 0 313661 304634 306637 287637
T = 4 298626 143628* 306637 136663#
Body
temperature,
(uC)
T = 0 36.661.2 36.660.6 37.160.8 36.660.4
T = 4 37.460.5 24.861.6* 36.761.3 26.061.4#
AST, U/L 1946186 121633 89644 98647
ALT, U/L 1276143{ 62626 47611 49612
Creatinine, mmol/L 5069 2763* 4067 2364#
GFR, mL/min 1.460.4 5.262.8* 2.061.6 2.461.4
Kidney wet weight, g 1.6260.13{ 1.4660.09* 1.1960.37 1.3860.06
Urine protein, mg/mL 0.7160.58{ 0.2960.39* 0.1660.25 0.1360.14
Data are means 6 SD.
*Pneumonia+saline vs. pneumonia+NaHS,
#healthy+saline vs. healthy+NaHS,
{pneumonia vs. healthy, p,0.05.
MAP: mean arterial pressure, AST: aspartate aminotransferase, ALT: alanine
transaminase, GFR: glomerular filtration rate.
doi:10.1371/journal.pone.0063497.t001
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Figure 1. NaHS reduced lung injury parameters in pneumosepsis. The number of cells (A), neutrophil influx (B), total protein (C), interleukin
(IL)–6 (E), TNF–a (F), IL–1b (G) and CINC3 (H) in animals infected with S. pneumoniae and healthy controls was determined in bronchoalveolar lavage
fluid (BALF). The right lung lobes were used to determine lung wet weight (D). Mean 6 SEM, (n = 6 in the pneumonia group infused with NaHS and
n= 8 in the other experimental groups). *: p,0.05.
doi:10.1371/journal.pone.0063497.g001
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NaHS Prevented a Fall in Bio-energetic Status by
Maintaining Mitochondrial Function and by Upregulation
of Mitochondrial Biogenesis
Infusion of NaHS prevented the observed increase in levels of
protein carbonyls (p,0.05, figure 3A+B) in pneumonia compared
to non-infected controls. In line with reduced oxidative stress,
NaHS prevented the fall in active oxidative phosphorylation
observed during pneumonia when challenged with substrate for
complex I (p,0.05, figure 3C), together with an increase in ATP
concentration and ATP/ADP ratio (p,0.05, figure 3G+H).
Infusion of NaHS had no effect on the expression of VDAC,
but resulted in upregulation of a-tubulin and the fraction of
phosphorylated PKCe as regulators of VDAC in liver mitochon-
dria (p,0.05, figure 4C–F). Effects of NaHS infusion on
parameters of mitochondrial function differed between the lung,
which was the primary diseased site, and the liver, a sentinel organ
in regulating metabolism. In the lung, the effect of NaHS on
regulators of VDAC was not observed. Furthermore, we found
that infusion of NaHS reduced levels of COX1 and tended to
reduce levels of NADH1 in BALF, suggesting less leakage of
damaged lung mitochondria (figure S3 B+D). Circulating levels of
COX1, NADH1 and NADH6 were decreased in a non-significant
fashion by NaHS.
Besides improved mitochondrial function, NaHS infusion
increased expression of liver PGC-1a, which is the main
mitochondrial transcription factor (p,0.05, figure 5). NaHS also
upregulated PGC1-a in healthy controls, indicating an ubiquitous
effect of NaHS. In line with these results, hepatic NADH1
Figure 2. NaHS reduced histopathologic abnormalities and interstitial inflammation in pneumosepsis. Total histopathology score (A)
and interstitial inflammation (B) with representative photographs of hematoxylin and eosin stained lung tissue sections (magnification620) of
animals infected with S. pneumoniae infused with saline (C) or NaHS (D) and healthy controls (E+F). (n = 6 in the pneumonia group infused with NaHS
and n= 8 in the other experimental groups). Mean 6 SEM, *:p,0.05. Inserts represents interstitial inflammation.
doi:10.1371/journal.pone.0063497.g002
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Figure 3. NaHS reduces oxidative damage and improved complex I mitochondrial respiration and ATP availability in
pneumosepsis. Lung (A) and liver (B) protein carbonyls levels, with mitochondrial O2 consumption during oxidative phosphorylation of glutamate
and malate (C+D), mitochondrial O2 consumption during oxidative phosphorylation of succinate (E+F) and concentrations of ATP (G) and ATP/ADP
ratio (H) in animal infected with S. pneumoniae and healthy controls infused with saline or NaHS. Mitochondrial O2 consumption was recorded during
NaHS Reduces Organ Injury in Pneumosepsis
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expression increased and NADH6 expression tended to increase
after NaHS infusion (figure 5F+H). Both are subunits of
mitochondrial respiratory complexes. Taken together, these results
may point to an enhanced mitochondrial biogenesis. Of note, we
again found differences between the lung and liver. Upregulation
of factors involved in mitochondrial biogenesis was noted in the
liver, but not in the (diseased) lung.
Discussion
In this model of pneumococcal pneumosepsis, infusion of H2S-
donor NaHS reduced organ damage, associated with maintained
mitochondrial integrity by reducing oxidative damage as well as
with increased mitochondrial biogenesis, which may both have
contributed to a reversal of inhibition of mitochondrial oxygen
consumption and increased ATP bio-availability.
NaHS reduced lung injury by inhibiting inflammatory process-
es, in accordance with previous findings in non-infectious models
of acute lung injury caused by smoke inhalation [22] or induced by
mechanical ventilation [18]. NaHS reduced pulmonary neutrophil
influx and protein leakage in the alveolar compartment during
pneumonia. Preservation of the endothelial barrier may have been
a mechanism of the observed decrease in distant organ injury in
this study, as biomarkers of endothelial damage have been found
in blood of patients with pneumonia, contributing to multiple
organ failure [23].
Acute kidney injury is a common complication of pneumosepsis,
with an important impact on outcome [24]. In our model,
pneumonia resulted in edema of the kidney, with urinary protein
loss and deterioration of kidney function. Infusion of NaHS
reversed the fall in the glomerular filtration rate and kidney
function both in pneumonia as well as in healthy animals,
suggesting that NaHS improved perfusion of the kidney. Decrease
of protein leakage may presumably be due to anti-inflammatory
effects of NaHS, thereby preserving the endothelial barrier in the
glomeruli, comparable to effects in the pulmonary compartment.
NaHS tended to decrease liver cell damage, as reflected in
decreased levels of both AST and ALT. We presume that
significance was not reached due to a large variation in the levels
of the liver enzymes, which would possibly be overcome with
larger group size.
Under normal conditions, the electron transport chain com-
plexes in the inner mitochondrial membrane are involved in
formation of ATP. In sepsis, complex I and II are susceptible to
damage, [25] which may lead to decreased ATP concentrations at
cellular levels. We found that in pneumonia, mitochondrial
respiration was decreased when challenged with substrate for
complex I, accompanied by reduced ATP and ATP/ADP ratios,
while respiration with substrate for complex II was unchanged.
This is in line with findings in human septic shock [5]. Low ATP
levels in combination with a high expression of VDAC and
impaired oxygen consumption during pneumonia, is suggestive of
an increased need for ATP in the presence of mitochondrial
damage, presumably due to increased levels of pro-inflammatory
cytokines and reactive oxygen species, as found in this study.
In sepsis, reactive oxygen species not only damage mitochon-
drial respiratory complexes, but also other vital proteins [26],
thereby forming protein carbonyls [27]. We found a reduction of
protein carbonyls after NaHS infusion, which may have contrib-
uted to reversal of the fall in mitochondrial respiration, together
with increased ATP levels. With respect to the mechanism of
improved mitochondrial respiration, we found that NaHS
increased the expression of proteins in the mitochondrial fraction
which induce closure of VDAC, including a-tubulin [12] and
PKCe [28]. VDAC is considered an important regulator of
mitochondrial respiration [29]. We suggest that NaHS preserves
mitochondrial function during sepsis by increasing expression of
mitochondrial a-tubulin and PKCe, thereby closing VDAC and
stabilizing the mitochondrial membrane [30], resulting in preser-
vation of oxidative phosphorylation. However, as we did not
measure activity of other ATP-ADP transporters, definite state-
ments about the mechanisms of improved ATP bioavailability
cannot be made.
Another indication that mitochondrial damage was limited by
NaHS is the finding that levels of mtDNA in the bronchoalveolar
lavage fluid were reduced, suggesting less leakage of mitochondria
[31]. As circulating or shed mtDNA invokes an inflammatory
response in sepsis and trauma [31], a reduction in damaged
mitochondria may have contributed to the protective effect of
NaHS in this study. Although systemic mtDNA levels were non-
significantly reduced after NaHS, we found a trend in decrease for
all subunits, suggestive of a lack of power to demonstrate a
significant effect.
Besides maintaining oxidative phosphorylation, we also found
evidence for an improved mitochondrial biogenesis after NaHS
infusion, as concluded from the upregulated expression of PGC1-a
and transcription factors coding for respiratory complexes in
pneumonia. Similarly to the effects of NaHS on mitochondria,
other gas molecules like carbon monoxide and nitric oxide are able
to enhance mitochondrial biogenesis [32].
The effects of NaHS on regulators of mitochondrial function
were most evident in the liver, but not in the lung. The liver is a
sentinel organ in regulating metabolism [32,33], whereas the lung
is not. Also, the lungs in this study were considerably damaged by
pneumonia, which may underlie a lack of effect on mitochondrial
biogenesis.
We previously reported that NaHS reversibly reduced metab-
olism in anesthetized rats [18], akin to the induction of a
suspended animation like-state [17]. It has been stated that
reducing metabolism with concomitant hypothermia may render
the host more susceptible to infection [34,35], although infection
risk differs among studies [34–36]. We did not find enhanced
dissemination of bacteria during the hypothermic period. In
contrast, there was a tendency to local containment of bacteria.
This may result from the improved endothelial barrier function by
NaHS, thereby inhibiting dissemination. However, an important
question remains whether bacteria restart replicating after
cessation of NaHS.
It may be argued that observed protective effects are
attributable to hypothermia induced by NaHS. Although mild
hypothermia reduces inflammation [37–39], detrimental effects of
deep hypothermia have been reported in experimental settings
[40,41] and in humans [42]. In accordance, induction of deep
hypothermia that paralleled effects of NaHS either worsened lung
inflammation or had no effect in a rat model of ventilator induced
lung injury [18,43] or shock [44,45]. Thereby, we hypothesize that
reducing metabolism by inhibiting mitochondrial respiration by
NaHS while not allowing to reduce body temperature may be
toxic.
state 3 and state 4 respirations in liver. Mean 6 SEM, (n = 6 in the pneumonia group infused with NaHS and n= 8 in the other experimental groups).
*p,0.05.
doi:10.1371/journal.pone.0063497.g003
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Figure 4. NaHS increased protein level of a-tubulin and protein kinase C (PKC)-e as regulators of voltage dependent anion channel
(VDAC) in pneumosepsis. Protein levels of VDAC (A+B), a-tubulin (C+D) and PKC-e (E+F) on two separate immunoblots in lung and in liver freezed
clamp biopsies of animals infected with S. pneumoniae or healthy controls infused with saline or NaHS. Data represent mean 6 SEM from 6 animals
per group. VDAC and a-tubulin are given as a ratio of prohibitin (PHB) expression. Phosphorylated PKC-e is given as a ratio of total PKC-e. Data as
mean 6 SEM, *: p,0.05.
doi:10.1371/journal.pone.0063497.g004
Figure 5. NaHS increased mitochondrial biogenesis by up regulation of expression of PGC-1a and mitochondrial respiratory
subunits in the liver. The expression of peroxisome proliferator–activated receptor gamma (PGC)-1a (A+B), COX1 (C+D), NADH1 (E+F) and NADH6
(G+H) at mRNA level in lung and liver in animals infected with S. pneumoniae or healthy controls infused with saline or NaHS. Data represent mean6
SEM from n=6 in the pneumonia group infused with NaHS and n=8 in the other experimental groups. Data as mean 6 SEM, *: p,0.05.
doi:10.1371/journal.pone.0063497.g005
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A limitation of this study may be that mitochondrial respiration
was measured at 37uC, which does not represent the in vivo
situation in NaHS infused animals. However, as the technique was
the same in all groups, limitations pertaining to the measurement
cannot explain differences between NaHS and controls. Finally,
we did not measure H2S concentrations in tissue, which is a
limitation to our study. However, NaHS infusion may be a more
feasible treatment strategy than H2S gas administration. There-
fore, we consider results of this study relevant for future studies
evaluating the use of NaHS in sepsis.
Conclusion
In this model of severe pneumosepsis, NaHS reduced local and
distant organ injury, associated with maintaining mitochondrial
function as well as with improving mitochondrial biogenesis.
Interventions aimed at stabilizing bio-energetic status may be a
therapeutic approach to reduce organ failure in pneumosepsis.
Supporting Information
Figure S1 NaHS did not reduce bacterial outgrowth. The
number of colonizing forming units (CFU) in bronchoalveolar
lavage fluid (BALF) (A), lung (B), liver (C) and spleen (D)
homogenates in animals infected with S. pneumoniae were
determined by 10 fold dilutions on blood agar plates (n = 8 in
pneumonia group and n= 6 in the NaHS group). Horizontal line
indicates the mean (log scale).
(TIF)
Figure S2 NaHS reduced systemic levels of interleukin (IL)–6 in
pneumonia. The concentrations of IL–6 (A), tumor necrosis factor
(TNF)–a (B), IL–1b (C) and CINC3 (D) in plasma of animals
infected with S. pneumoniae and healthy controls infused with saline
or H2S. (n = 6 in the pneumonia group infused with H2S and n= 8
in the other experimental groups). Mean 6 SEM. *: p,0.05.
(TIF)
Figure S3 NaHS maintained mitochondrial integrity reflected
by low levels of mitochondrial DNA in bronchoalveolar lavage
fluids (BALF). The expression of COX1 (A+B), NADH1 (C+D)
and NADH6 (E+F) in plasma and in BALF in animals infected
with S. pneumoniae or healthy controls infused with saline or H2S.
Data represent mean 6 SEM from n=6 in the pneumonia group
infused with NaHS and n=8 in the other experimental groups.
(TIF)
Table S1
(DOC)
Methods S1
(DOCX)
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